5.33

6.81% 0.34

Optimizerx Corp (OPRX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Optimizerx Corp stock is traded at $5.33, with a volume of 179.56K. It is up +6.81% in the last 24 hours and down -2.38% over the past month. OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

Previous Close:

$4.99

Open:

$5.02

24h Volume:

179.56K

Relative Volume:

0.86

Market Cap:

$96.71M

Revenue:

$62.81M

Net Income/Loss:

$-13.75M

P/E Ratio:

-6.50

EPS:

-0.82

Net Cash Flow:

$153.00K

1W Performance:

+20.59%

1M Performance:

-2.38%

6M Performance:

-58.81%

1Y Performance:

-43.72%

1-Day Range:

$5.015

$5.485

1-Week Range:

$4.3216

$5.485

52-Week Range:

$3.78

$16.64

Optimizerx Corp Stock (OPRX) Company Profile

Name

Optimizerx Corp

Sector

Healthcare (1200)

Industry

Health Information Services (60)

Phone

248-651-6558

Address

260 CHARLES STREET, WALTHAM, MI

Employee

136

Twitter

@OpRxTweets

Next Earnings Date

2024-11-13

Latest SEC Filings

OPRX's Discussions on Twitter

Compare OPRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OPRX Optimizerx Corp	5.33	96.71M	62.81M	-13.75M	153.00K	-0.82
VEEV Veeva Systems Inc	226.76	36.93B	2.57B	615.26M	996.76M	3.32
SOLV Solventum Corp	72.48	12.43B	8.26B	66.00M	1.17B	0.00
TEM Tempus Ai Inc	62.98	10.01B	640.44M	-743.28M	-206.93M	0.00
DOCS Doximity Inc	53.39	9.94B	493.63M	160.55M	162.20M	0.55
HQY Healthequity Inc	102.47	8.91B	1.10B	105.67M	-197.98M	0.1475

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-25-24	Resumed	B. Riley Securities	Buy
Apr-04-24	Initiated	JMP Securities	Mkt Outperform
Jan-03-24	Initiated	Barclays	Equal Weight
Feb-02-23	Resumed	B. Riley Securities	Buy
Nov-01-22	Initiated	Stifel	Buy
Jul-15-22	Initiated	SVB Leerink	Outperform
Oct-18-21	Resumed	B. Riley Securities	Buy
Apr-13-21	Initiated	RBC Capital Mkts	Outperform
Jan-03-19	Initiated	William Blair	Outperform

View All

Optimizerx Corp Stock (OPRX) Latest News

Nov 22, 2024

OptimizeRx to Present at ROTH and Canaccord Genuity Healthcare Conferences in NYC | OPRX Stock News - StockTitan

Nov 18, 2024

Janney Montgomery Scott LLC Buys Shares of 104,917 OptimizeRx Co. (NASDAQ:OPRX) - Defense World

Nov 18, 2024

Nov 17, 2024

Brokerages Set OptimizeRx Co. (NASDAQ:OPRX) Price Target at $11.58 - Defense World

Nov 17, 2024

Nov 15, 2024

OptimizeRx Corporation (NASDAQ:OPRX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

Nov 14, 2024

AWM Investment Company's Strategic Acquisition of OptimizeRx Cor - GuruFocus.com

Nov 14, 2024

Divisadero Street Capital Management's Strategic Acquisition of OptimizeRx Shares - GuruFocus.com

Nov 14, 2024

OptimizeRX shares target cut, maintains buy rating on lower revenue - Investing.com

Nov 14, 2024

OptimizeRx's (OPRX) "Buy" Rating Reiterated at Roth Mkm - MarketBeat

Nov 14, 2024

Optimizerx stock hits 52-week low at $4.69 amid market challenges - Investing.com Nigeria

Nov 14, 2024

Earnings call: OptimizeRx reports 30% revenue growth in Q3 By Investing.com - Investing.com UK

Nov 14, 2024

OptimizeRx (NASDAQ:OPRX) Price Target Cut to $8.00 by Analysts at Stifel Nicolaus - MarketBeat

Nov 14, 2024

JMP Securities Lowers OptimizeRx (NASDAQ:OPRX) Price Target to $8.00 - MarketBeat

Nov 14, 2024

OptimizeRx (NASDAQ:OPRX) Given New $5.00 Price Target at Barclays - MarketBeat

Nov 14, 2024